Published in Liver Transpl on January 01, 2010
Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42
Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol (2012) 1.08
Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization. World J Gastroenterol (2012) 0.96
Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol (2015) 0.94
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci (2013) 0.93
Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States. Liver Transpl (2011) 0.88
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. World J Gastroenterol (2012) 0.86
Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol (2014) 0.84
Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. HPB (Oxford) (2015) 0.84
Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol (2015) 0.83
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit (2012) 0.81
Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol (2012) 0.79
Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol (2014) 0.79
Mesenteric ischaemia secondary to portomesenteric venous thrombosis, 2 weeks post laparoscopic sleeve gastrectomy in a cirrhotic patient. BMJ Case Rep (2014) 0.78
Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol (2014) 0.78
A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Indian J Med Res (2014) 0.78
Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol (2015) 0.77
Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol (2013) 0.77
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open (2013) 0.76
FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT. Asia Ocean J Nucl Med Biol (2015) 0.76
A case report of simultaneous orthotopic liver transplantation and jejunectomy. BMC Surg (2016) 0.75
Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. World J Hepatol (2017) 0.75
Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study. World J Gastroenterol (2015) 0.75
Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World J Hepatol (2016) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology (2008) 4.73
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol (2013) 3.41
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol (2012) 3.04
Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev (2012) 2.57
Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One (2011) 2.48
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol (2005) 2.26
MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology (2008) 2.19
Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg (2010) 2.01
Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology (2011) 1.98
Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl (2007) 1.96
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology (2008) 1.95
Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology (2011) 1.94
Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis (2005) 1.93
Association of center volume with outcome after liver and kidney transplantation. Am J Transplant (2004) 1.92
Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl (2013) 1.88
Seasonal variation in surgical outcomes as measured by the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg (2007) 1.81
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology (2010) 1.80
Morphometric age and surgical risk. J Am Coll Surg (2013) 1.73
Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomy. J Am Coll Surg (2011) 1.73
Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl (2007) 1.69
Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66
Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg (2012) 1.65
Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark (2007) 1.65
Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg (2006) 1.65
Incremental costs of post-liver transplantation complications. J Am Coll Surg (2007) 1.63
Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant (2003) 1.62
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl (2007) 1.61
Contact isolation in surgical patients: a barrier to care? Surgery (2003) 1.60
Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res (2005) 1.55
SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology (2005) 1.55
Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl (2009) 1.49
Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) (2012) 1.49
Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl (2005) 1.48
Financial implications of surgical complications in pediatric liver transplantation. Pediatr Transplant (2008) 1.48
There is plenty for everyone: transection of the infracardiac inferior vena cava during organ recovery. Liver Transpl (2012) 1.48
Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg (2011) 1.47
Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery. Ann Surg (2010) 1.47
A tale of two provinces: regionalization of pancreatic surgery in Ontario and Quebec. Ann Surg Oncol (2010) 1.47
Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.46
Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology (2012) 1.44
Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000. Dig Dis Sci (2013) 1.43
Is routine ureteral stenting cost-effective in renal transplantation? J Urol (2007) 1.41
Transfusions in surgical patients. J Am Coll Surg (2005) 1.40
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol (2013) 1.39
Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol (2004) 1.39
Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med (2003) 1.34
Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol (2007) 1.33
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl (2009) 1.31
Frailty and delayed graft function in kidney transplant recipients. Arch Surg (2012) 1.30
Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl (2008) 1.30
A statewide assessment of surgical site infection following colectomy: the role of oral antibiotics. Ann Surg (2010) 1.29
The Michigan surgical quality collaborative: will a statewide quality improvement initiative pay for itself? Ann Surg (2007) 1.27
Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma (2005) 1.22
Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant (2002) 1.21
Antibiotic choice is independently associated with risk of surgical site infection after colectomy: a population-based cohort study. Ann Surg (2013) 1.20
Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. AJR Am J Roentgenol (2006) 1.17
Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes. Biochem Biophys Res Commun (2003) 1.13
Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol (2013) 1.11
Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation (2002) 1.09
Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol (2010) 1.09
Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant (2005) 1.09
Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant (2004) 1.05
Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep (2008) 1.05
Patient decision making about organ quality in liver transplantation. Liver Transpl (2011) 1.04
Perturbation of thymocyte development in nonsense-mediated decay (NMD)-deficient mice. Proc Natl Acad Sci U S A (2011) 1.03
Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg (2010) 1.01
Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg (2002) 1.00
Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res (2007) 0.98
Liver and intestine transplantation. Am J Transplant (2004) 0.97
Gender imbalance in living donor renal transplantation. Transplantation (2002) 0.97
Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol (2013) 0.97
Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis. Gastrointest Endosc (2011) 0.96
Kidney transplantation from organ donors following cardiopulmonary death using extracorporeal membrane oxygenation support. Ann Transplant (2004) 0.96
Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging (2010) 0.96
Nature of gram-negative rod antibiotic resistance during antibiotic rotation. Surg Infect (Larchmt) (2005) 0.95
Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl (2003) 0.95
Long-term follow-up of percutaneous transhepatic balloon cholangioplasty in the management of biliary strictures after liver transplantation. Transplantation (2004) 0.94
Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci (2010) 0.94
Current approaches to the treatment of early hepatocellular carcinoma. Oncologist (2010) 0.93
Resident workload, pager communications, and quality of care. World J Surg (2010) 0.93
Staging systems for hepatocellular carcinoma: should we all use the BCLC system? J Hepatol (2006) 0.92
Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA. Transplantation (2003) 0.92
Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice. Clin Gastroenterol Hepatol (2004) 0.92
Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C. Transplantation (2008) 0.92
Screening process failures for hepatocellular carcinoma. J Natl Compr Canc Netw (2014) 0.90
Hepatocellular carcinoma. Curr Opin Gastroenterol (2004) 0.90
Viral hepatitis and hepatocellular carcinoma. Arch Med Res (2007) 0.90
Early urologic complications after pediatric renal transplant: a single-center experience. Transplantation (2008) 0.89
Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci (2011) 0.88